513 related articles for article (PubMed ID: 31572390)
1. Chemokines in Physiological and Pathological Bone Remodeling.
Brylka LJ; Schinke T
Front Immunol; 2019; 10():2182. PubMed ID: 31572390
[TBL] [Abstract][Full Text] [Related]
2. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.
Takayanagi H
Nat Rev Immunol; 2007 Apr; 7(4):292-304. PubMed ID: 17380158
[TBL] [Abstract][Full Text] [Related]
3. Osteoimmunology: Influence of the Immune System on Bone Regeneration and Consumption.
Limmer A; Wirtz DC
Z Orthop Unfall; 2017 Jun; 155(3):273-280. PubMed ID: 28683495
[No Abstract] [Full Text] [Related]
4. Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL.
Kassem A; Lindholm C; Lerner UH
PLoS One; 2016; 11(6):e0156708. PubMed ID: 27311019
[TBL] [Abstract][Full Text] [Related]
5. Role of CX3CL1/fractalkine in osteoclast differentiation and bone resorption.
Koizumi K; Saitoh Y; Minami T; Takeno N; Tsuneyama K; Miyahara T; Nakayama T; Sakurai H; Takano Y; Nishimura M; Imai T; Yoshie O; Saiki I
J Immunol; 2009 Dec; 183(12):7825-31. PubMed ID: 19923448
[TBL] [Abstract][Full Text] [Related]
6. The emerging field of osteoimmunology.
Mensah KA; Li J; Schwarz EM
Immunol Res; 2009 Dec; 45(2-3):100-13. PubMed ID: 19184540
[TBL] [Abstract][Full Text] [Related]
7. Inflammation in bone physiology and pathology.
Adamopoulos IE
Curr Opin Rheumatol; 2018 Jan; 30(1):59-64. PubMed ID: 29016371
[TBL] [Abstract][Full Text] [Related]
8. S1P-S1PR1 Signaling: the "Sphinx" in Osteoimmunology.
Xiao L; Zhou Y; Friis T; Beagley K; Xiao Y
Front Immunol; 2019; 10():1409. PubMed ID: 31293578
[TBL] [Abstract][Full Text] [Related]
9. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
10. Osteoimmunology--the hidden immune regulation of bone.
Caetano-Lopes J; Canhão H; Fonseca JE
Autoimmun Rev; 2009 Jan; 8(3):250-5. PubMed ID: 18722561
[TBL] [Abstract][Full Text] [Related]
11. Afamin secreted from nonresorbing osteoclasts acts as a chemokine for preosteoblasts via the Akt-signaling pathway.
Kim BJ; Lee YS; Lee SY; Park SY; Dieplinger H; Ryu SH; Yea K; Choi S; Lee SH; Koh JM; Kim GS
Bone; 2012 Sep; 51(3):431-40. PubMed ID: 22749887
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid: a potential mediator of osteoblast-osteoclast signaling in bone.
Sims SM; Panupinthu N; Lapierre DM; Pereverzev A; Dixon SJ
Biochim Biophys Acta; 2013 Jan; 1831(1):109-16. PubMed ID: 22892679
[TBL] [Abstract][Full Text] [Related]
13. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the phenotypic and functional heterogeneity of mouse inflammatory osteoclasts by the expression of
Madel MB; Ibáñez L; Ciucci T; Halper J; Rouleau M; Boutin A; Hue C; Duroux-Richard I; Apparailly F; Garchon HJ; Wakkach A; Blin-Wakkach C
Elife; 2020 May; 9():. PubMed ID: 32400390
[TBL] [Abstract][Full Text] [Related]
15. Impaired bone formation and increased osteoclastogenesis in mice lacking chemokine (C-C motif) ligand 5 (Ccl5).
Wintges K; Beil FT; Albers J; Jeschke A; Schweizer M; Claass B; Tiegs G; Amling M; Schinke T
J Bone Miner Res; 2013 Oct; 28(10):2070-80. PubMed ID: 23553711
[TBL] [Abstract][Full Text] [Related]
16. The tight relationship between osteoclasts and the immune system.
Del Fattore A; Teti A
Inflamm Allergy Drug Targets; 2012 Jun; 11(3):181-7. PubMed ID: 22280239
[TBL] [Abstract][Full Text] [Related]
17. TNF and Bone Remodeling.
Zhao B
Curr Osteoporos Rep; 2017 Jun; 15(3):126-134. PubMed ID: 28477234
[TBL] [Abstract][Full Text] [Related]
18. The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review.
Xu J; Yu L; Liu F; Wan L; Deng Z
Front Immunol; 2023; 14():1222129. PubMed ID: 37475866
[TBL] [Abstract][Full Text] [Related]
19. Fas/S1P
Hutami IR; Izawa T; Mino-Oka A; Shinohara T; Mori H; Iwasa A; Tanaka E
Biochem Biophys Res Commun; 2017 Sep; 490(4):1274-1281. PubMed ID: 28687489
[TBL] [Abstract][Full Text] [Related]
20. Immune Function and Diversity of Osteoclasts in Normal and Pathological Conditions.
Madel MB; Ibáñez L; Wakkach A; de Vries TJ; Teti A; Apparailly F; Blin-Wakkach C
Front Immunol; 2019; 10():1408. PubMed ID: 31275328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
